trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Liver Cirrhosis D008103 67 associated lipids
Myeloproliferative Disorders D009196 5 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Fibrosis D005355 23 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Carcinoma, Renal Cell D002292 12 associated lipids
Immunologic Deficiency Syndromes D007153 8 associated lipids
Leukemia, Promyelocytic, Acute D015473 3 associated lipids
Stroke D020521 32 associated lipids
Leukemia, Myeloid D007951 52 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Hobbs CA and Gilmour SK High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation. 2000 J. Cell. Biochem. pmid:10760944
Yoshida M and Horinouchi S [Histone deacetylase inhibitors--new anticancer agents?]. 2000 Tanpakushitsu Kakusan Koso pmid:10771678
Yu F et al. Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2. 2000 Nucleic Acids Res. pmid:10773092
Kitamura K et al. Histone deacetylase inhibitor but not arsenic trioxide differentiates acute promyelocytic leukaemia cells with t(11;17) in combination with all-trans retinoic acid. 2000 Br. J. Haematol. pmid:10792271
Saleh M et al. Cell signaling switches HOX-PBX complexes from repressors to activators of transcription mediated by histone deacetylases and histone acetyltransferases. 2000 Mol. Cell. Biol. pmid:11046157
Andoh A et al. Modulation of complement component (C3 and factor B) biosynthesis by a histone deacetylase inhibitor in human intestinal epithelial cells. 2000 Int. J. Mol. Med. pmid:10851266
Siavoshian S et al. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. 2000 Gut pmid:10716680
Jin S et al. Ecteinascidin 743, a transcription-targeted chemotherapeutic that inhibits MDR1 activation. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10841572
Claassen GF and Hann SR A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10920185
Mao C and Shapiro DJ A histone deacetylase inhibitor potentiates estrogen receptor activation of a stably integrated vitellogenin promoter in HepG2 cells. 2000 Endocrinology pmid:10875235
Clayton AL et al. Phosphoacetylation of histone H3 on c-fos- and c-jun-associated nucleosomes upon gene activation. 2000 EMBO J. pmid:10899125
Kang J et al. Heat shock protein 90 mediates protein-protein interactions between human aminoacyl-tRNA synthetases. 2000 J. Biol. Chem. pmid:10913161
Yu J et al. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. 2000 Mol. Cell. Biol. pmid:10713181
Adachi N et al. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation. 2000 Gene pmid:10713444
Shin JY et al. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. 2000 Cancer Res. pmid:10667572
Hodny Z et al. Sp1 and chromatin environment are important contributors to the formation of repressive chromatin structures on the transfected human adenine nucleotide translocase-2 promoter. 2000 Biochem. J. pmid:10657244
Garrison PM et al. Effects of histone deacetylase inhibitors on the Ah receptor gene promoter. 2000 Arch. Biochem. Biophys. pmid:10666294
Smith RD et al. Quantitative PCR analysis of HbF inducers in primary human adult erythroid cells. 2000 Blood pmid:10648397
Nakayama T et al. Epigenetic regulation of androgen receptor gene expression in human prostate cancers. 2000 Lab. Invest. pmid:11140692
Dressel U et al. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer. 2000 Mar-Apr Anticancer Res. pmid:10810390
Steinbac OC et al. Histone deacetylase activity is required for the induction of the MyoD muscle cell lineage in Xenopus. 2000 Sep-Oct Biol. Chem. pmid:11076034
Deltour S et al. Characterization of HRG22, a human homologue of the putative tumor suppressor gene HIC1. 2001 Biochem. Biophys. Res. Commun. pmid:11554746
Kiela PR et al. Regulation of the rat NHE3 gene promoter by sodium butyrate. 2001 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:11557515
Bovenzi V and Momparler RL Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. 2001 Cancer Chemother. Pharmacol. pmid:11488527
Franco PJ et al. The orphan nuclear receptor TR2 interacts directly with both class I and class II histone deacetylases. 2001 Mol. Endocrinol. pmid:11463856
Sutherland JE et al. The histone deacetylase inhibitor trichostatin A reduces nickel-induced gene silencing in yeast and mammalian cells. 2001 Mutat. Res. pmid:11470494
Takakura M et al. Telomerase activation by histone deacetylase inhibitor in normal cells. 2001 Nucleic Acids Res. pmid:11452025
Ferraro M et al. Involvement of histone H4 acetylation in the epigenetic inheritance of different activity states of maternally and paternally derived genomes in the mealybug Planococcus citri. 2001 Chromosoma pmid:11453559
Marianna P et al. Valproic acid, trichostatin and their combination with hemin preferentially enhance gamma-globin gene expression in human erythroid liquid cultures. 2001 Haematologica pmid:11454524
Pujuguet P et al. Trichostatin A inhibits beta-casein expression in mammary epithelial cells. 2001 J. Cell. Biochem. pmid:11746508
Matsusue K et al. Characterization of mouse metastasis-associated gene 2: genomic structure, nuclear localization signal, and alternative potentials as transcriptional activator and repressor. 2001 DNA Cell Biol. pmid:11749719
Lavelle D et al. Histone deacetylase inhibitors increase p21(WAF1) and induce apoptosis of human myeloma cell lines independent of decreased IL-6 receptor expression. 2001 Am. J. Hematol. pmid:11754398
Williams RJ Trichostatin A, an inhibitor of histone deacetylase, inhibits hypoxia-induced angiogenesis. 2001 Expert Opin Investig Drugs pmid:11785457
Jordan A et al. The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. 2001 EMBO J. pmid:11285236
Bachl J et al. Increased transcription levels induce higher mutation rates in a hypermutating cell line. 2001 J. Immunol. pmid:11290786
Mishra N et al. Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-gamma gene and protein expression in lupus T cells. 2001 Proc. Natl. Acad. Sci. U.S.A. pmid:11226290
Ding BC et al. Association of deletions and translocation of the reduced folate carrier gene with profound loss of gene expression in methotrexate-resistant K562 human erythroleukemia cells. 2001 Biochem. Pharmacol. pmid:11266651
Segev H et al. Expression patterns of histone deacetylases in bovine oocytes and early embryos, and the effect of their inhibition on embryo development. 2001 Zygote pmid:11358320
Archer SY et al. p21 gene regulation during enterocyte differentiation. 2001 J. Surg. Res. pmid:11368530
Ma J et al. Regulation of zygotic gene activation in the preimplantation mouse embryo: global activation and repression of gene expression. 2001 Biol. Reprod. pmid:11369600
Della Ragione F et al. Genes modulated by histone acetylation as new effectors of butyrate activity. 2001 FEBS Lett. pmid:11423116
Feng YQ et al. Position effects are influenced by the orientation of a transgene with respect to flanking chromatin. 2001 Mol. Cell. Biol. pmid:11113204
Mehra-Chaudhary R et al. Msx3 protein recruits histone deacetylase to down-regulate the Msx1 promoter. 2001 Biochem. J. pmid:11115394
Kosugi H et al. In vivo effects of a histone deacetylase inhibitor, FK228, on human acute promyelocytic leukemia in NOD / Shi-scid/scid mice. 2001 Jpn. J. Cancer Res. pmid:11376562
Zhu WG et al. DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. 2001 Cancer Res. pmid:11245429
Muth V et al. Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription. 2001 EMBO J. pmid:11250901
Laribee RN and Klemsz MJ Loss of PU.1 expression following inhibition of histone deacetylases. 2001 J. Immunol. pmid:11673528
Biade S et al. Chemical agents that promote chromatin compaction radiosensitize tumour cells. 2001 Int. J. Radiat. Biol. pmid:11682008
Mishra SK et al. Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells. 2001 FEBS Lett. pmid:11682064
Sharma M and Sun Z 5'TG3' interacting factor interacts with Sin3A and represses AR-mediated transcription. 2001 Mol. Endocrinol. pmid:11682623